AI-generated summary
This review describes the retinal pigment epithelium's roles in the eye and its dysfunction in age-related macular degeneration, a leading cause of blindness in developed countries. The authors report that photobiomodulation targets mechanisms of RPE dysfunction implicated in AMD. They state that current evidence for its efficacy in AMD is poor, although its safety profile and proposed mechanisms motivate further research.
- Who or what was studied
- unclear
- Wavelengths
- 630, 1000 nm
- Limits stated in the abstract
- The authors state that current evidence for the efficacy of photobiomodulation in AMD is poor.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630-1000 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Age-related macular degeneration, Photobiomodulation, Oxidative stress, Near-infrared, Photoreceptor, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.